Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 330 M334 M328 M348 M349 M362 M 1.39 B Research & development —————— — Operating income 5.03 B5.25 B5.49 B5.61 B5.78 B6.02 B 22.89 B Non-Operating Income, Total -2 M00-7 M28 M-139 M -118 M Interest expense, net of interest capitalized 2.65 B2.71 B2.88 B2.65 B2.48 B2.59 B 10.6 B Non-Operating Income, excl. Interest Expenses -2.66 B-2.71 B-2.88 B-2.66 B-2.46 B-2.73 B -10.72 B Unusual income/expense —————— — Pretax income 1.85 B2.02 B2.29 B2.33 B2.19 B2.59 B 9.39 B Equity in earnings —————— — Taxes 347 M381 M465 M296 M415 M531 M 1.71 B Non-controlling/minority interest 18 M16 M14 M13 M12 M15 M 54 M After tax other income/expense —————— — Net income before discontinued operations 1.48 B1.64 B1.82 B2.03 B1.76 B2.04 B 7.66 B Discontinued operations —————— — Net income 1.48 B1.64 B1.82 B2.03 B1.76 B2.04 B 7.66 B Dilution adjustment -29 M-28 M-28 M-28 M-12 M-14 M -82 M Preferred dividends 71 M83 M71 M83 M73 M85 M 312 M Diluted net income available to common stockholders 1.4 B1.53 B1.72 B1.92 B1.68 B1.94 B 7.26 B Basic earnings per share (Basic EPS) 3.523.864.364.864.134.82 18.17 Diluted earnings per share (Diluted EPS) 3.513.854.354.884.134.81 18.17 Average basic shares outstanding 398 M397 M396 M396 M405 M403 M — Diluted shares outstanding 398 M397 M396 M396 M405 M403 M — EBITDA —————— — EBIT 5.03 B5.25 B5.49 B5.61 B5.78 B6.02 B 22.89 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —